I think the big names are a distraction, after all, it would be easy to get a tiny order for a trial from an office manager somewhere in a big organisation for a trial, and then put their name on the list. I would want to see that what management are telling us reconciles with the accounts. To me, admittedly with only 20 years experience evaluating such things (not always getting it right admittedly), it doesn't appear to reconcile. But maybe the market is willing to pay per name on the list, and not worry about cashflows, revenues, receipts, receivables and other misleading nonsense ;-).
Well - don't let me put anybody off if you know that will boost the SP, and you will make money on it. The market has been a bit like that recently if you have picked the right stocks.
Add to My Watchlist
What is My Watchlist?